<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hjortdal J</submitter><funding>Agence Nationale de la Recherche</funding><pagination>2337-2347</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9796948</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(10)</volume><pubmed_abstract>Acute rejection (AR) of corneal transplants (CT) has a profound effect on subsequent graft survival but detailed immunological studies in human CT recipients are lacking. In this multi-site, cross-sectional study, clinical details and blood samples were collected from adults with clinically diagnosed AR of full-thickness (FT)-CT (n = 35) and posterior lamellar (PL)-CT (n = 21) along with Stable CT recipients (n = 177) and adults with non-transplanted corneal disease (n = 40). For those with AR, additional samples were collected 3 months later. Immune cell analysis was performed by whole-genome microarrays (whole blood) and high-dimensional multi-color flow cytometry (peripheral blood mononuclear cells). For both, no activation signature was identified within the B cell and T cell repertoir</pubmed_abstract><journal>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</journal><pubmed_title>Peripheral blood immune cell profiling of acute corneal transplant rejection.</pubmed_title><pmcid>PMC9796948</pmcid><funding_grant_id>ANR‐10‐IBHU‐005</funding_grant_id><funding_grant_id>ANR‐17‐CE17‐0008</funding_grant_id><pubmed_authors>Brouard S</pubmed_authors><pubmed_authors>Griffin MD</pubmed_authors><pubmed_authors>Pleyer U</pubmed_authors><pubmed_authors>Bylesjo M</pubmed_authors><pubmed_authors>Karakachoff M</pubmed_authors><pubmed_authors>Armitage WJ</pubmed_authors><pubmed_authors>Hjortdal J</pubmed_authors><pubmed_authors>Gabhann PM</pubmed_authors><pubmed_authors>Gourraud PA</pubmed_authors><pubmed_authors>Walkinshaw MD</pubmed_authors><pubmed_authors>Degauque N</pubmed_authors><pubmed_authors>Vabres B</pubmed_authors><pubmed_authors>Cadoux M</pubmed_authors><pubmed_authors>Murphy CC</pubmed_authors><pubmed_authors>Tole D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Peripheral blood immune cell profiling of acute corneal transplant rejection.</name><description>Acute rejection (AR) of corneal transplants (CT) has a profound effect on subsequent graft survival but detailed immunological studies in human CT recipients are lacking. In this multi-site, cross-sectional study, clinical details and blood samples were collected from adults with clinically diagnosed AR of full-thickness (FT)-CT (n = 35) and posterior lamellar (PL)-CT (n = 21) along with Stable CT recipients (n = 177) and adults with non-transplanted corneal disease (n = 40). For those with AR, additional samples were collected 3 months later. Immune cell analysis was performed by whole-genome microarrays (whole blood) and high-dimensional multi-color flow cytometry (peripheral blood mononuclear cells). For both, no activation signature was identified within the B cell and T cell repertoir</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2025-04-04T10:59:08.34Z</modification><creation>2025-04-04T10:59:08.34Z</creation></dates><accession>S-EPMC9796948</accession><cross_references><pubmed>35704290</pubmed><doi>10.1111/ajt.17119</doi></cross_references></HashMap>